Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
Philips’ Dr Carla Goulart Peron on AI, equity and the future of care
How can AI expand healthcare access without losing the human touch? Philips’ CMO Dr Carla Goulart Peron shares all.
Read more
Routine vaccinations: road to recovery
The pharmaceutical industry needs to help restoring pre-pandemic routine vaccination levels and protect populations worldwide.
World Health Day 2023: Health for All
Today is World Health Day, and to celebrate GOLD asked Claire Gillis, CEO, VMLY&R Health, to share her thoughts on using creativity to create better access to healthcare for all
Behind the hype of ChatGPT
Now that the world has had time to see the risks and rewards of ChatGPT, pharma industry must decide whether to take it or leave it. Read for more.
The changing rhythm of digital therapeutics
Digital therapeutics are making their way onto the main stage, and pharma should be taking note. What lies ahead for potential partnerships?
Taking a bet on blockchain
GOLD explores what the pharmaceutical industry’s future might look like with the adoption of blockchain technology within its key functions.
Bridging the digital health divide
Technology has redefined the exchange of health information. Find out how the pharma industry can help patients build confidence about digital health tools.
Nurturing home-grown innovation in Europe
Europe is a front runner for pharmaceutical research and thought leadership Find out in what measure this is translating into home-grown innovation.
Reacting to supply chain risks
The pharmaceutical supply chain is vulnerable to adverse events, and the pandemic has served as a reminder of how these networks can be tested. The industry has learned tough lessons from COVID-19 that must be translated into modernisation and improvements
Loading posts...
« Previous
1
…
18
19
20
21
22
…
33
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View